Endometrial Cancer

Endometrial cancer is the most common form of gynecological cancer. The vast majority of patients (90%) develop abnormal bleeding, which makes early diagnosis easier and therefore the possibility of a cure.

Most cancers of the endometrium are diagnosed at stage 1, when the tumor is localized in the uterus.

The risk of a woman developing this type of cancer during her lifetime is 2.62%, with a mortality rate of 0.5%.


There are two types of endometrial cancer.

Type 1 is most commonly related to an excess of endogenic or exogenic hormones (estrogen). The amount of estrogen is not offset by progesterone, causing hyperplasia of the endometrium, which eventually leads to cancer.

Type 2 is less frequent, but it is more aggressive and is not related to a hormonal imbalance. There is no epidemiological profile for type 2.


The treatment for endometrial cancer is a hysterectomy with bilateral ovariectomy.

A pelvic lymphadenectomy, which indicates whether the disease has spread to the lymph nodes, is usually performed.

The uterus, ovaries and lymph nodes are analyzed by a pathologist and, based on results, the care team may recommend additional preventive radiotherapy.

Back to the topics of interest list